← FDA DRUG APPROVALS

FDA ANDA · ANDA087504

CHLOROQUINE PHOSPHATE

Sponsor: TEVA

APPLICATION
ANDA087504
TYPE
ANDA
ORIGINAL APPROVAL
1982-01-13
LATEST ACTION
1992-01-10
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

CHLOROQUINE PHOSPHATEDiscontinued
CHLOROQUINE PHOSPHATE 250MG · TABLET · ORAL

Approval history

1992-01-10Labeling · Supplement 18AP
1991-11-06Manufacturing (CMC) · Supplement 17AP
1991-03-26Manufacturing (CMC) · Supplement 16AP
1989-08-04Labeling · Supplement 15AP
1987-07-01Manufacturing (CMC) · Supplement 12AP
1987-07-01Manufacturing (CMC) · Supplement 9AP
1986-06-23Manufacturing (CMC) · Supplement 14AP
1986-06-23Manufacturing (CMC) · Supplement 13AP
1985-01-03Manufacturing (CMC) · Supplement 10AP
1985-01-03Manufacturing (CMC) · Supplement 11AP
1984-11-02Manufacturing (CMC) · Supplement 8AP
1984-02-16Manufacturing (CMC) · Supplement 7AP
1983-01-26Manufacturing (CMC) · Supplement 4AP
1983-01-26Manufacturing (CMC) · Supplement 2AP
1983-01-26Manufacturing (CMC) · Supplement 5AP
1983-01-26Manufacturing (CMC) · Supplement 3AP
1982-01-13OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →